haylaavo

J B CHEMICALS AND PHARMA

JBCHEPHARM · NSE · inactive
2,408.90
-97.10 (-3.87%)
as of 16 Jul 2026 close
Open
2,506.00
High
2,525.50
Low
2,380.00
Prev close
2,506.00
52w high
2,525.50
16 Jul 2026
52w low
1,638.50
26 Sept 2025
VWAP
2,418.56
Delivery %
66.8%
of volume
Volume 47.79 L · turnover ₹1155.88 Cr · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 02 Feb 1995
Series
EQ
F&O
No
Status
Inactive since 17 Jul 2026

Source: NSE equity master · as of 16 Jul 2026

Market cap
—
P/B
—
ROE (TTM)
17.1%
ROCE 23.0%
Debt / equity
0.00
P/E (TTM)
—
P/S (TTM)
—
Revenue TTM
₹4,148 cr
Net profit TTM
₹709 cr
Net margin TTM
17.1%
OPM 26.0%
EV / EBITDA
—
Interest cover
172.0×
Revenue growth
-4.8%
latest quarter YoY
Profit growth
-30.4%
latest quarter YoY
Dividend yield
—
₹22 / share · payout —

Consolidated · last four quarters to 2026-03-31 · balance sheet 2026-03-31 · tap a tile for the formula

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 22:59 IST
  • 14 May 2025 20:25
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Ashwani Kumar Puri as Non- Executive Independent Director of the company w.e.f. May 14, 2025.

    PDF · -
  • 14 May 2025 20:25
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Sumit Bose as Non- Executive Independent Director of the company w.e.f. August 31, 2025.

    PDF · -
  • 14 May 2025 19:47
    Dividend

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 14, 2025, recommended Final Dividend of Rs. 7 per equity share.

    PDF · -
  • 14 May 2025 19:41
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

    PDF · -
  • 14 May 2025 19:41
    Business update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 14, 2025, titled "Press Release".

    PDF · -
  • 14 May 2025 19:34
    Board meeting

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 14, 2025.

    PDF · -
  • 14 May 2025 13:40
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of meet

    PDF · -
  • 06 May 2025 07:46
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 65686 Shares.

    PDF · -
  • 23 Apr 2025 11:18
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of meet

    PDF · -
  • 18 Apr 2025 14:30
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'ANDA Approval by US FDA'.

    PDF · -
  • 14 Apr 2025 17:34
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

    PDF · -
  • 04 Apr 2025 18:24
    Insider / SAST

    Tau Investment Holdings Pte. Ltd. has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

    PDF · -
  • 02 Apr 2025 17:34
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Noting of Cautionary letter received from the Exchanges'.

    PDF · -
  • 02 Apr 2025 17:31
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015

    PDF · -
  • 29 Mar 2025 15:44
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

    PDF · -
  • 28 Mar 2025 16:11
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

    PDF · -
  • 18 Mar 2025 16:11
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 1700 Shares.

    PDF · -
  • 14 Mar 2025 16:49
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'USFDA inspection of Company s API manufacturing facility D9 at Panoli, Gujarat'.

    PDF · -
  • 08 Mar 2025 16:37
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'USFDA inspection of Company s manufacturing facility T20 at Panoli, Gujarat'.

    PDF · -
  • 05 Mar 2025 14:47
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'DJSI (Dow Jones Sustainable Index) ESG Score release'.

    PDF · -
  • 28 Feb 2025 10:57
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015

    PDF · -
  • 27 Feb 2025 15:07
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 69180 Shares.

    PDF · -
  • 19 Feb 2025 16:43
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Intimation of schedule of Analysts/Institutional investors meet

    PDF · -
  • 19 Feb 2025 16:38
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015

    PDF · -
  • 10 Feb 2025 18:09
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript

    PDF · -
  • 05 Feb 2025 14:49
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Link of Recording

    PDF · -
  • 05 Feb 2025 12:38
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper cutting of extract of consolidated financial results for quarter ended on December 31, 2024

    PDF · -
  • 04 Feb 2025 19:53
    Results

    Integrated filing (Financial) for the quarter and nine months ended December 31, 2024

    PDF · -
  • 04 Feb 2025 19:36
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Board comments on fine levied by the Exchange for delayed compliance'.

    PDF · -
  • 04 Feb 2025 19:18
    Corporate action

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 08-Feb-2025.

    PDF · -
  • 04 Feb 2025 19:15
    Dividend

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on February 04, 2025, declared Interim Dividend of 8.50 per equity share.

    PDF · -
  • 04 Feb 2025 19:04
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

    PDF · -
  • 04 Feb 2025 19:04
    Business update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 04, 2025, titled "Press Release".

    PDF · -
  • 04 Feb 2025 18:58
    Results

    JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.

    PDF · -
  • 04 Feb 2025 17:00
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015

    PDF · -
  • 24 Jan 2025 18:24
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of meet

    PDF · -
  • 24 Jan 2025 11:19
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 57600 Shares.

    PDF · -
  • 16 Jan 2025 16:10
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015'.

    PDF · -
  • 16 Jan 2025 16:10
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Presentation'.

    PDF · -
  • 07 Jan 2025 18:18
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

    PDF · -
  • 27 Dec 2024 14:30
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

    PDF · -
  • 18 Dec 2024 14:28
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 36120 Shares.

    PDF · -
  • 06 Dec 2024 16:16
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme'.

    PDF · -
  • 20 Nov 2024 18:36
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 95300 Shares.

    PDF · -
  • 12 Nov 2024 12:07
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript

    PDF · -
  • 07 Nov 2024 17:47
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Link of Recording

    PDF · -
  • 07 Nov 2024 17:28
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates

    PDF · -
  • 07 Nov 2024 17:08
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper cutting of extract of consolidated financial results for quarter ended on September 30, 2024

    PDF · -
  • 07 Nov 2024 12:45
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

    PDF · -
  • 06 Nov 2024 19:47
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Board commentson fine levied by the Exchange'.

    PDF · -
Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries